Washington, June 1 ANI | 6 months ago

A new research has revealed that through a device an analysis of organic compounds in exhaled breath can test for patients with lung cancer and it can also determine the stage of any cancer present.

Fred R. Hirsch, MD, PhD said that the study could totally revolutionize lung cancer diagnosis and the perspective here was the development of a non-traumatic, easy, cheap approach to early detection and differentiation of lung cancer.

They could also eventually measure the change in patients' levels of VOCs across time with the intent of, for example, monitoring how well a patient responds to specific treatments, he added.

The process involves a balloon, which a person has to blow and it is then attached to a really sensitive gold nanoparticle sensor, after that the particles in the sensor trap and they help to evaluate volatile organic compounds in the exhaled breath.

(Posted on 01-06-2014)

Share This Page:


Post your comments